Skip to content
10-Q

Quarterly Report

Dianthus Therapeutics, Inc. DNTH

0001193125-25-266920

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 42.88M sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.79M sh
Shares Diluted Q3 2025 · Sep 30, 2025 36.48M sh
Shares Diluted Q3 2025 · Sep 30, 2024 34.24M sh
Shares Diluted Q3 2025 · Sep 30, 2024 32.61M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$82.08M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$50.74M
Short Term Investments Q3 2025 · Sep 30, 2025 $346.63M
Short Term Investments Q3 2025 · Dec 31, 2024 $252.45M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $55.98M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.79M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $33.67M
Stockholders Equity Q3 2025 · Sep 30, 2025 $546.45M
Stockholders Equity Q3 2025 · Jun 30, 2025 $303.08M
Stockholders Equity Q3 2025 · Mar 31, 2025 $328.61M
Stockholders Equity Q3 2025 · Dec 31, 2024 $352.48M
Stockholders Equity Q3 2025 · Sep 30, 2024 $337.9M
Stockholders Equity Q3 2025 · Jun 30, 2024 $358.22M
Stockholders Equity Q3 2025 · Mar 31, 2024 $372.69M
Stockholders Equity Q3 2025 · Dec 31, 2023 $168.87M
Current Liabilities Q3 2025 · Sep 30, 2025 $23.86M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.45M
Total Liabilities Q3 2025 · Sep 30, 2025 $30.99M
Total Liabilities Q3 2025 · Dec 31, 2024 $21.53M
Current Assets Q3 2025 · Sep 30, 2025 $413.83M
Current Assets Q3 2025 · Dec 31, 2024 $280.9M
Total Assets Q3 2025 · Sep 30, 2025 $577.45M
Total Assets Q3 2025 · Dec 31, 2024 $374.01M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.97
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.68
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.74
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.73
Eps Basic Q3 2025 · Sep 30, 2025 −$0.97
Eps Basic Q3 2025 · Sep 30, 2025 −$2.68
Eps Basic Q3 2025 · Sep 30, 2024 −$0.74
Eps Basic Q3 2025 · Sep 30, 2024 −$1.73
Sga Expense Q3 2025 · Sep 30, 2025 $8.2M
Sga Expense Q3 2025 · Sep 30, 2025 $24.4M
Sga Expense Q3 2025 · Sep 30, 2024 $6.53M
Sga Expense Q3 2025 · Sep 30, 2024 $18.17M
Rd Expense Q3 2025 · Sep 30, 2025 $32.49M
Rd Expense Q3 2025 · Sep 30, 2025 $85.74M
Rd Expense Q3 2025 · Dec 31, 2024 $87.9M
Rd Expense Q3 2025 · Sep 30, 2024 $25.54M
Rd Expense Q3 2025 · Sep 30, 2024 $56.69M
Net Income Q3 2025 · Sep 30, 2025 −$36.77M
Net Income Q3 2025 · Sep 30, 2025 −$97.91M
Net Income Q3 2025 · Jun 30, 2025 −$31.63M
Net Income Q3 2025 · Mar 31, 2025 −$29.51M
Net Income Q3 2025 · Sep 30, 2024 −$25.17M
Net Income Q3 2025 · Sep 30, 2024 −$56.53M
Net Income Q3 2025 · Jun 30, 2024 −$17.61M
Net Income Q3 2025 · Mar 31, 2024 −$13.75M
Operating Income Q3 2025 · Sep 30, 2025 −$40.29M
Operating Income Q3 2025 · Sep 30, 2025 −$108.39M
Operating Income Q3 2025 · Sep 30, 2024 −$29.9M
Operating Income Q3 2025 · Sep 30, 2024 −$69.95M
Revenue Q3 2025 · Sep 30, 2025 $396K
Revenue Q3 2025 · Sep 30, 2025 $1.75M
Revenue Q3 2025 · Sep 30, 2024 $2.17M
Revenue Q3 2025 · Sep 30, 2024 $4.91M